This is a textbook bullish insider cluster: two top executives (CFO and COO) buying $700K open-market on the same day at the same price, representing ~1% of market cap. Per the Cohen/Malloy/Pomorski literature, cluster buys from C-suite are the most predictive insider signal. The cross-filing actuarial verdicts confirm this cluster is an amplifier when combined with other context. Monitor for upcoming catalysts (pipeline updates, partnership news, or earnings) that may have motivated these purchases. The $15 level now serves as a key insider cost basis support.
Price Chart
Executive Summary
Apollomics CFO and COO made open-market purchases totaling $700K at $15/share, representing ~1% of the $68M market cap. This is a material insider cluster buy from two top executives, the strongest signal in the insider dataset per academic literature.
Key Financial Metrics
Key Facts
- CFO LIN PETER KUAN-HOW bought 26,667 shares at $15.00 for $400,005
- COO Chen Yi-Kuei bought 20,000 shares at $15.00 for $300,000
- Total insider purchases of $700,005 represent ~1.03% of the $68M market cap
- Both transactions were open-market purchases (code P), not grants or exercises
- Cluster occurred on a single day (2026-08-14), suggesting coordinated conviction
Financial Impact
Two C-suite executives invested $700K of personal capital at $15/share, representing ~1% of market cap — a highly material insider buy cluster for a $68M company
Risk Factors
- Biotech pre-revenue companies carry binary clinical trial risk that can overwhelm any insider signal
- Small market cap ($68M) means low liquidity and high volatility
- Insider buys at a micro-cap biotech may reflect optimism about a specific pipeline candidate that could fail
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-APLM-1787011830873 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 10w ago | Insider Cluster | $23.92 $26.50 | ▲ +10.79% | ▲ +10.99% | $19.90 (−16.81%) |
Aug 17, 2026 10w ago | Insider Cluster | $23.92 $26.50 | ▲ +10.79% | ▲ +10.99% | $19.90 (−16.81%) |
Aug 17, 2026 10w ago | Insider Cluster | $23.92 $26.50 | ▲ +10.79% | ▲ +10.99% | $19.90 (−16.81%) |
Aug 17, 2026 10w ago | Insider Cluster | $23.92 $26.50 | ▲ +10.79% | ▲ +10.99% | $19.90 (−16.81%) |
Jul 21, 2026 13w ago | 6-K | $18.71 $18.00 | ▼ −3.77% | ▼ −2.54% | $19.90 (+6.39%) |
Jul 14, 2026 14w ago | 6-K | $15.70 $18.86 | ▲ +20.13% | ▲ +21.42% | $19.90 (+26.75%) |
Jun 24, 2026 17w ago | 6-K | $22.00 $20.16 | ▲ +8.36% | ▲ +9.92% | $19.90 (+9.55%) |
Apr 27, 2026 26w ago | Press Release | $13.19 $16.47 | ▲ +24.84% | ▲ +24.44% | $19.90 (+50.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers